Empresa Briacell Therapeutics Corp Toronto S.E.
Acciones
CA10778Y1043
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01/11/16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01/02/16 |
Chief Tech/Sci/R&D Officer | 53 | 01/05/21 | |
Chief Tech/Sci/R&D Officer | 62 | 16/02/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10/05/16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31/08/21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07/03/18 |
Director/Board Member | 66 | 18/03/19 | |
William Williams
CEO | Chief Executive Officer | 68 | 01/11/16 |
Jane Gross
BRD | Director/Board Member | 67 | 01/11/21 |
Chairman | 39 | 04/02/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 15 981 726 | 14 020 125 ( 87,73 %) | 0 | 87,73 % |
Información de la empresa
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-1,05 % | 21,96 mil M | |
-14,15 % | 21,87 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |